Hillstream Biopharma Stock Net Asset
HILSDelisted Stock | USD 0.39 0.01 2.50% |
Hillstream Biopharma fundamentals help investors to digest information that contributes to Hillstream Biopharma's financial success or failures. It also enables traders to predict the movement of Hillstream Stock. The fundamental analysis module provides a way to measure Hillstream Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hillstream Biopharma stock.
Hillstream |
Hillstream Biopharma Company Net Asset Analysis
Hillstream Biopharma's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Hillstream Biopharma Net Asset | 6.69 M |
Most of Hillstream Biopharma's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hillstream Biopharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
CompetitionBased on the recorded statements, Hillstream Biopharma has a Net Asset of 6.69 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Hillstream Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hillstream Biopharma's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hillstream Biopharma could also be used in its relative valuation, which is a method of valuing Hillstream Biopharma by comparing valuation metrics of similar companies.Hillstream Biopharma is currently under evaluation in net asset category among its peers.
Hillstream Fundamentals
Return On Equity | -1.47 | |||
Return On Asset | -0.78 | |||
Current Valuation | 496.66 K | |||
Shares Outstanding | 17.53 M | |||
Shares Owned By Insiders | 38.90 % | |||
Shares Owned By Institutions | 0.80 % | |||
Number Of Shares Shorted | 52.74 K | |||
Price To Book | 0.88 X | |||
EBITDA | (6.88 M) | |||
Net Income | (8.47 M) | |||
Cash And Equivalents | 9.48 M | |||
Cash Per Share | 0.82 X | |||
Total Debt | 772.9 K | |||
Current Ratio | 13.13 X | |||
Book Value Per Share | 0.18 X | |||
Cash Flow From Operations | (6.56 M) | |||
Short Ratio | 0.20 X | |||
Earnings Per Share | (0.76) X | |||
Target Price | 4.0 | |||
Market Capitalization | 4.23 M | |||
Total Asset | 6.69 M | |||
Retained Earnings | (15.38 M) | |||
Working Capital | 5.54 M | |||
Z Score | -2.34 | |||
Net Asset | 6.69 M |
About Hillstream Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hillstream Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hillstream Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hillstream Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Hillstream Stock
If you are still planning to invest in Hillstream Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hillstream Biopharma's history and understand the potential risks before investing.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Money Managers Screen money managers from public funds and ETFs managed around the world |